UK markets closed

Mineralys Therapeutics, Inc. (MLYS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
13.00-0.15 (-1.14%)
At close: 04:00PM EDT
13.00 0.00 (0.00%)
After hours: 04:01PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
88,822
70,361
26,250
16,308
2,411
Selling general and administrative
16,259
14,296
5,229
2,417
532
Total operating expenses
105,081
84,657
31,479
18,725
2,943
Operating income or loss
-105,081
-84,657
-31,479
-18,725
-2,943
Interest expense
-
-
-
27
115
Total other income/expenses net
3
3
4
-656
-368
Income before tax
-90,798
-71,898
-29,799
-19,408
-3,426
Income from continuing operations
-90,798
-71,898
-29,799
-19,408
-3,426
Net income
-90,798
-71,898
-29,799
-19,408
-3,426
Net income available to common shareholders
-90,798
-71,898
-29,799
-19,408
-3,426
Basic EPS
-1.38
-
-0.76
-3.77
-0.35
Diluted EPS
-1.38
-
-0.76
-3.77
-0.35
Basic average shares
41,105
-
39,057
5,153
9,910
Diluted average shares
41,105
-
39,057
5,153
9,910